Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies in the United States and internationally. It offers DyeVert Plus EZ and DyeVert Power XT, and DyeVert Plus Systems, which are used to protect patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.
| Market Capitalization | $6.4146 million |
| P/E Ratio | |
| P/E Growth Ratio | 0 |
| Book Value | 0.202 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.558 |
| EBITDA | -17,997.78 |
| Profit Margin | 0 |
| Operating Margin TTM | -6.3513 |
| Return on Assets TTM | -1.0412 |
| Return on Equity TTM | -2.0965 |
| Revenue TTM | 1,960.265 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2012-12-31 | 5,539.744 | |||
| 2013-12-31 | 0 | 0 | 0 | 8,740.106 |
| 2014-12-31 | 7.72 | 202.89 | 7.72 | 9,883.842 |
| 2015-12-31 | 173.09 | 371.66 | 173.09 | 12,531.354 |
| 2016-12-31 | 585.14 | 743.812 | -158.672 | 11,729.528 |
| 2017-12-31 | 1,630.615 | 1,393.72 | 1,630.615 | 16,271.677 |
| 2018-12-31 | 2,514.117 | 1,384.277 | 1,129.84 | 19,263.07 |
| 2019-12-31 | 3,665.142 | 1,767.868 | 1,897.274 | 20,415.881 |
| 2020-12-31 | 1,671.868 | 1,223.687 | 448.181 | 14,138.695 |
| 2021-12-31 | 1,960.265 | 1,255.05 | 705.215 | 13,445.877 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2012-12-31 | 15,156.333 | 15,777.924 | 620.379 | 37,826.774 | ||
| 2013-12-31 | 12,985.166 | 21,314.606 | 1,251.903 | 3,584.69714 | 51,340.506 | |
| 2014-12-31 | 4,142.808 | 12,334.932 | 1,226.86 | 8,755.49866 | 52,109.02 | |
| 2015-12-31 | 11,784.567 | 12,604.666 | 962.765 | 64,805.907 | ||
| 2016-12-31 | 21,853.439 | 22,978.528 | 1,341.764 | 86,537.275 | ||
| 2017-12-31 | 32,134.848 | 34,142.948 | 1,784.135 | 111,595.735 | ||
| 2018-12-31 | 25,251.79 | 27,533.97 | 1,999.376 | 122,293.483 | ||
| 2019-12-31 | 8,276.72 | 10,818.668 | 2,740.093 | 125.241 | 122,913.847 | |
| 2020-12-31 | 5,787.03 | 7,888.101 | 3,493.253 | 1,456.974 | 132,608.19 | |
| 2021-12-31 | 5,386.483 | 7,059.607 | 1,870.538 | 143.8 | 143,448.892 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2012-12-31 | -5,878.507320000001 | 13,054.54642 | 1,541.3058600000002 | 14,595.85227 | ||
| 2013-12-31 | -9,620.668310000001 | -7,000 | -2,426.42713 | 16,938.23536 | 14,511.80823 | |
| 2014-12-31 | -11,854.60254 | -8,852.655 | -10,780.733970000001 | 15,831.706900000001 | 5,050.97293 | |
| 2015-12-31 | -16,648.03997 | -11,563.96 | 10,459.56611 | 5,670.4188300000005 | 16,129.98494 | |
| 2016-12-31 | -16,219.603369999999 | -10,523.699 | 13,914.9696 | 16,286.02405 | 30,200.99364 | |
| 2017-12-31 | -14,336.411 | -13,846.238 | 13,181.29359 | 28,017.229489999998 | 41,198.52308 | |
| 2018-12-31 | -17,521.967 | -16,761.007 | -9,752.13658 | 45,529.6798 | 35,777.54321 | |
| 2019-12-31 | -18,056.837 | -16,866.587 | -24,229.332 | 36,043.09164 | 11,813.75963 | |
| 2020-12-31 | -13,378.07 | -12,707.135 | -3,232.52402 | 10,746.19579 | 7,513.67177 | |
| 2021-12-31 | -10,046.481 | -11,664.845 | -400.547 | 5,787.03 | 5,386.483 |